share_log

亞盛醫藥-B:自願公告 - 亞盛醫藥四項研究入選,耐立克治療SDH缺陷型GIST最新進展獲口頭報告

ASCENTAGE-B: VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA TO PRESENT FOUR STUDIES, INCLUDING AN ORAL REPORT FEATURING THE LATEST DATA OF OLVEREMBATINIB IN SDH-DEFICIENT GIST

Hong Kong Stock Exchange ·  Apr 24 18:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more